Biotech startups that raised a pre-seed round in the United States
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Aikium Inc. | Berkeley | Pre-seed | $1.0M | 2026-03-01 |
| LiveGrow Bio | Richland | Pre-seed | $150K | 2025-10-06 |
| Anjo.ai | New York | Pre-seed | $610K | 2025-09-01 |
| Izote Biosciences | Berkeley | Pre-seed | $3.1M | 2025-02-01 |
| Rowan | Boston | Pre-seed | $2.1M | 2024-12-09 |
| Raycaster | New York | Pre-seed | $500K | 2024-12-04 |
| Reticular | San Francisco | Pre-seed | $500K | 2024-12-04 |
| Dannce.ai | Boston | Pre-seed | $2.6M | 2024-11-21 |
8 rows of the CSV in 5 of its 18 columns.
- The 424 biotech startups in the United States whose last round is a pre-seed round have raised $320.2M in total.
- 87 of them closed their most recent round in the last 12 months, $48.2M combined.
- The largest of those rounds is Sift Biosciences' $3.8M pre-seed round, dated December 2025.
- The most recent is Praetorian Bio's $1.3M pre-seed round on 26 October 2026.
- Y Combinator is an investor in 18 of them, more than any other fund.
- Health care is the most common other sector, with 272 companies (64%).
- 70% were founded in 2020 or later; the median founding year is 2022.
- The most common team size is 1 to 10 employees (78% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
22 of 424| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Aikium Inc. | Aikium combines deep learning and synthetic biology to develop novel protein therapeutics. | Artificial intelligence | Berkeley | Pre-seed | $1.0M | 2026-03-01 | $5.0M | Bantam Group, Half Court Ventures, Civilization Ventures +2 | 1 to 10 | 2022 |
| LiveGrow Bio | LiveGrow Bio is a biotechnology company that manufactures low-cost microbial products with long room-temperature shelf life. | Biotech | Richland | Pre-seed | $150K | 2025-10-06 | $512K | MassChallenge Switzerland, Fuse Fund | 1 to 10 | 2019 |
| Izote Biosciences | Izote Biosciences offers a solution for scaling up biomanufacturing. | Biotech | Berkeley | Pre-seed | $3.1M | 2025-02-01 | $3.1M | Bee Partners, Nucleus Capital, Courtyard Ventures +2 | 1 to 10 | 2022 |
| Crane Biosciences | Crane Biosciences develops gene therapies that use RBCNPs to evade the immune system. | Biotech | Delaware | Pre-seed | $125K | 2024-06-03 | $125K | Norrsken Evolve | 1 to 10 | 2022 |
| SynsoryBio | SynsoryBio is a biotechnology research company that offers protein therapeutics services. | Biotech | Somerville | Pre-seed | $500K | 2024-04-03 | $500K | Y Combinator | 1 to 10 | 2023 |
| Artos | Artos is an AI document-drafting platform that turns life sciences data and reports into submission packages. | Artificial intelligence | San Francisco | Pre-seed | $500K | 2024-02-27 | $500K | Y Combinator, Pioneer Fund | 1 to 10 | 2023 |
| Velorum Therapeutics | Velorum Therapeutics develops cancer treatments that starve tumors of their blood supply. | Biotech | South San Francisco | Pre-seed | $500K | 2024-02-27 | $500K | Y Combinator, Eight Capital | 1 to 10 | 2023 |
| Eris Biotech | Eris Biotech develops hypoxia-activated prodrugs for the treatment of solid tumors. | Biotech | American Fork | Pre-seed | $500K | 2024-02-08 | $500K | Y Combinator | 1 to 10 | 2023 |
| HopeAI | HopeAI provides AI-powered clinical evidence for drug development and precision medicine. | Artificial intelligence | Princeton | Pre-seed | $1.1M | 2024-01-15 | $1.1M | Plug and Play, Taihill Venture, PKSHA Capital | 1 to 10 | 2023 |
| Carez AI | Carez AI builds vision models designed to perform reliably in real-world conditions. | Artificial intelligence | New York | Pre-seed | $150K | 2024-01-08 | $150K | (ERA) Entrepreneurs Roundtable Accelerator | 1 to 10 | 2024 |
| Syntopa | Syntopa develops precision biologics using proprietary methods and ag tech and synthetic biology. | Biotech | Alameda | Pre-seed | $575K | 2024-01-01 | $575K | Ponderosa Ventures | 1 to 10 | 2023 |
| Ohmic Biosciences | Ohmic Biosciences uses protein engineering to address diseases in crops. | Biotech | Alameda | Pre-seed | $500K | 2023-09-06 | $500K | Y Combinator | 1 to 10 | 2021 |
| OUI Medical | OUI Medical develops a first scope for examining the abdominal cavity. | Biotech | Dallas | Pre-seed | $400K | 2023-01-25 | $400K | Health Wildcatters | 1 to 10 | 2023 |
| Genobank.io | Genobank.io sells DNA kits and tracks genetic data sets and genome reports. | Biotech | Palo Alto | Pre-seed | $50K | 2022-10-31 | Expert Dojo, EOS VC Fund | 1 to 10 | 2017 | |
| Voythos | Voythos builds multimodal machine learning models that predict life-threatening complications in cardiovascular disease. | Artificial intelligence | Houston | Pre-seed | $180K | 2022-01-01 | $180K | Right Side Capital Management, Forum Ventures | 1 to 10 | 2021 |
| ImmunoMind | ImmunoMind develops cell therapies using multi-omics data. | Artificial intelligence | Berkeley | Pre-seed | $150K | 2022-01-01 | $755K | SkyDeck Berkeley | 11 to 50 | 2020 |
| Fitnescity Health | Fitnescity Health builds a platform offering a large range of wellness tests. | Biotech | Newark | Pre-seed | $250K | 2021-10-20 | $250K | Techstars, Right Side Capital Management, Goodwater Capital +1 | 11 to 50 | 2020 |
| Nephra | Nephra conducts biotechnology research. | Artificial intelligence | Champaign | Pre-seed | $70K | 2021-05-01 | $70K | VentureWell, iVenture Accelerator | 1 to 10 | 2021 |
| Facenote | Facenote builds a decentralized face recognition experience. | Artificial intelligence | Middletown | Pre-seed | $100K | 2021-03-30 | Techstars, Start-Up Chile, NXTP Ventures +2 | 1 to 10 | 2017 | |
| Kern Systems | Kern Systems builds scalable DNA data storage infrastructure using enzymes and software. | Biotech | Brookline | Pre-seed | $150K | 2019-08-19 | Y Combinator, Liquid 2 Ventures | 1 to 10 | 2019 | |
| Researchably | Researchably offers an AI platform that helps people make sense of biomedical research. | Artificial intelligence | Berkeley | Pre-seed | $100K | 2018-06-01 | $100K | Berkeley SkyDeck Fund | 11 to 50 | 2016 |
| aBioBot | aBioBot helps bio scientists make discoveries faster by shortening research timelines. | Biotech | Dublin | Pre-seed | $50K | 2015-02-03 | SOSV, SOSV SF & NY (Fka IndieBio) | 1 to 10 | 2015 |
Table 1. Biotech startups that raised a pre-seed round in the United States: the 22 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 424.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Aikium Inc. | Aikium combines deep learning and synthetic biology to develop novel protein therapeutics. | Artificial intelligence | Berkeley | Pre-seed | $1.0M | 2026-03-01 | $5.0M | Bantam Group, Half Court Ventures, Civilization Ventures +2 | 1 to 10 | 2022 |
Table 2. Biotech startups that raised a pre-seed round in the United States: the 1 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Y Combinator | Startup accelerator | Mountain View, United States | 18 | 4% | ||
| 2 | Techstars | Startup accelerator | New York, United States | 7 | 2% | ||
| 3 | GRID EXPONENTIAL | Startup accelerator | Buenos Aires, Argentina | 4 | 1% | 1 | GlycoX |
| 4 | MassChallenge Switzerland | Startup accelerator | Renens, Switzerland | 2 | 0% | ||
| 5 | SmartGateVC | Venture capital firm | Los Angeles, United States | 2 | 0% | ||
| 6 | 2048 Ventures | Venture capital firm | New York, United States | 2 | 0% | ||
| 7 | Forum Ventures | Startup accelerator | New York, United States | 2 | 0% | ||
| 8 | SOSV SF & NY (Fka IndieBio) | Venture capital firm | San Francisco, United States | 2 | 0% | ||
| 9 | SOSV | Venture capital firm | Princeton, United States | 2 | 0% | ||
| 10 | Plug and Play | Startup accelerator | Sunnyvale, United States | 2 | 0% | ||
| 11 | Alumni Ventures | Angel group | Manchester, United States | 2 | 0% | ||
| 12 | Innovation Works | Government investment office | Pittsburgh, United States | 2 | 0% | ||
| 13 | AlphaLab Health | Startup accelerator | Pittsburgh, United States | 2 | 0% | ||
| 14 | Expert Dojo | Startup accelerator | Santa Monica, United States | 2 | 0% | ||
| 15 | Antler | Venture capital firm | Singapore | 2 | 0% |
Table 3. Biotech startups that raised a pre-seed round in the United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 272 | 64% | $243.8M |
| Software | 167 | 39% | $110.9M |
| Artificial intelligence | 125 | 29% | $68.5M |
| Hardware | 20 | 5% | $5.8M |
| Education | 10 | 2% | $30.5M |
| Fintech | 7 | 2% | $2.6M |
| Commerce | 4 | 1% | $1.4M |
| Energy | 2 | 0% | $2.2M |
| Cybersecurity | 2 | 0% | $40K |
Table 4. Biotech startups that raised a pre-seed round in the United States by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 424 | 100% | $375K |
Table 5. Biotech startups that raised a pre-seed round in the United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| San Francisco | 80 | 19% |
| New York | 29 | 7% |
| Boston | 22 | 5% |
| Cambridge | 13 | 3% |
| Wilmington | 10 | 2% |
| Berkeley | 9 | 2% |
| San Diego | 8 | 2% |
| Dover | 8 | 2% |
| Chicago | 8 | 2% |
| Los Angeles | 8 | 2% |
| Seattle | 8 | 2% |
| Mountain View | 7 | 2% |
Table 6. Biotech startups that raised a pre-seed round in the United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 4 | 5% | $1.8M |
| September 2026 | 8 | 9% | $7.0M |
| August 2026 | 9 | 10% | $5.9M |
| July 2026 | 6 | 7% | $3.3M |
| June 2026 | 7 | 8% | $2.0M |
| May 2026 | 7 | 8% | $2.5M |
| April 2026 | 5 | 6% | $3.1M |
| March 2026 | 15 | 17% | $8.2M |
| February 2026 | 9 | 10% | $2.8M |
| January 2026 | 6 | 7% | $4.7M |
| December 2025 | 11 | 13% | $6.9M |
Table 7. Biotech startups that raised a pre-seed round in the United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 76 | 18% | $41.4M |
| 2025 | 69 | 16% | $38.2M |
| 2024 | 54 | 13% | $30.1M |
| 2023 | 57 | 13% | $26.2M |
| 2022 | 44 | 10% | $14.2M |
| 2021 | 24 | 6% | $8.2M |
Table 8. Biotech startups that raised a pre-seed round in the United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 186 | 46% |
| 2020 to 2022 | 96 | 24% |
| 2015 to 2019 | 86 | 21% |
| 2010 to 2014 | 28 | 7% |
| Before 2010 | 9 | 2% |
Table 9. Biotech startups that raised a pre-seed round in the United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 313 | 78% |
| 11 to 50 | 78 | 20% |
| 51 to 100 | 6 | 2% |
| 101 to 250 | 2 | 0% |
| 501 to 1,000 | 1 | 0% |
Table 10. Biotech startups that raised a pre-seed round in the United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is a pre-seed round and its headquarters is in the United States. On 16 November 2026 that is 424 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 22 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 424 rows: 160 have no round amount, 0 no city and 68 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in the United States whose last round is a pre-seed round are on the list?
- 424, in the file dated 16 November 2026. 87 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 424 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.